Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

The Brain Surgeon's Take

Dr. Eric Schulze: Cultivated Meat - The Future of Food

27 Jun 2024

Description

Eric Schulze, PhD is a professional molecular biologist, genetic engineer, and former federal biotechnology regulator. He is currently Founder and CEO of GOODHUMANS STRATEGY & DESIGN AGENCY, a full-service food innovation consultancy for a climate-changing world. Previously, Dr. Schulze has served as Vice President of Global Regulatory and Public Policy at UPSIDE FOODS, the world’s first cultivated meat company. At UPSIDE, he led the company’s regulatory-, policy-, and government affairs. Dr. Schulze and his team developed the policy and processes that brought the first-ever cultivated meat product to market in the US in 2023. Dr. Schulze also served in a company spokesperson capacity and launched the first-ever cultivated meat FSQA program, first regulatory affairs program, food product development program, and cell line development program.  Before the private sector, he served as a U.S. Food and Drug Administration regulator, handling a portfolio of novel food and drug biotechnology products. As a civil servant, Dr. Schulze also served as a federal STEM education policy capacity within the National Science Foundation and currently works with the National Academy of Sciences on undergraduate STEM education transformation. He holds an interdisciplinary doctorate in genetic, cellular, and molecular biology with a specialty in embryonic stem cell engineering from the University of Southern California (2010), a B.S. in Biological Sciences from Loyola University New Orleans (2005), and is trained in broadcast communication, speechwriting, and risk assessment.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.